FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma (Q33377159)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma |
scientific article |
Statements
1 reference
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma (English)
1 reference
Bhupinder S Mann
1 reference
John R Johnson
1 reference
Martin H Cohen
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
1 October 2007
1 reference
Identifiers
1 reference